Boostrix Intramuscular and Insulin glargine and lixisenatide
Determining the interaction of Boostrix Intramuscular and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diphtheria toxoid / pertussis, acellular / tetanus toxoid
Brand name: Adacel, Boostrix
Synonyms: Boostrix Vaccine, Boostrix
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Boostrix Intramuscular-Insulin glargine and lixisenatide Subcutaneous
- Boostrix Intramuscular-Insulin glargine, recombinant Subcutaneous
- Boostrix Intramuscular-Insulin glulisine
- Boostrix Intramuscular-Insulin Glulisine (Cartridges and Pens)
- Boostrix Intramuscular-Insulin Glulisine (Vials)
- Boostrix Intramuscular-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Boroleum
- Insulin glargine and lixisenatide-Bortezomib
- Insulin glargine and lixisenatide-Bortezomib Intravenous
- Insulin glargine and lixisenatide-Bosentan
- Insulin glargine and lixisenatide-Bosentan Tablets
- Insulin glargine and lixisenatide-Bosentan Tablets for Oral Suspension